404 related articles for article (PubMed ID: 6979443)
21. Native type II collagen-induced arthritis in the rat. Studies of the humoral response to collagen at the cellular level.
Ofosu-Appiah WA; Morgan K; Holt PJ
J Rheumatol; 1984 Aug; 11(4):432-7. PubMed ID: 6384504
[TBL] [Abstract][Full Text] [Related]
22. Assessment of drugs for activity in established type II collagen arthritis.
Jones SA; Kennedy AJ; Roberts NA
Agents Actions; 1982 Dec; 12(5-6):650-6. PubMed ID: 7164936
[TBL] [Abstract][Full Text] [Related]
23. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
24. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
[TBL] [Abstract][Full Text] [Related]
25. Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats.
Kamada H; Goto M; Matsuura S; Takaoka Y; Nagai H
Jpn J Pharmacol; 1997 Aug; 74(4):313-22. PubMed ID: 9307327
[TBL] [Abstract][Full Text] [Related]
26. Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis.
Verdrengh M; Isaksson O; Tarkowski A
Rheumatology (Oxford); 2005 Feb; 44(2):183-6. PubMed ID: 15494349
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis.
Grosios K; Wood J; Esser R; Raychaudhuri A; Dawson J
Inflamm Res; 2004 Apr; 53(4):133-42. PubMed ID: 15060719
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice.
Yu L; Ao M; Wan J; Zhang Y
Fitoterapia; 2008 Dec; 79(7-8):529-32. PubMed ID: 18672035
[TBL] [Abstract][Full Text] [Related]
29. Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies.
Malfait AM; Williams RO; Malik AS; Maini RN; Feldmann M
Arthritis Rheum; 2001 May; 44(5):1215-24. PubMed ID: 11352257
[TBL] [Abstract][Full Text] [Related]
30. Nonsteroidal anti-inflammatory agents in arthritis.
Ridolfo AS
Am Fam Physician; 1978 Feb; 17(2):131-8. PubMed ID: 622939
[TBL] [Abstract][Full Text] [Related]
31. Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats.
Lu S; Holmdahl R
Clin Immunol; 1999 Jan; 90(1):119-27. PubMed ID: 9884360
[TBL] [Abstract][Full Text] [Related]
32. The preventive effect of oral administration of type I interferon on collagen-induced arthritis in rats.
Yoshino S
Exp Mol Pathol; 1995 Apr; 62(2):123-30. PubMed ID: 8549696
[TBL] [Abstract][Full Text] [Related]
33. Rat adjuvant arthritis as a model to test potential antirheumatic agents.
Toivonen ML; Tokola O; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1982; 4(6):359-63. PubMed ID: 7144330
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
35. Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule-1.
Bullard DC; Hurley LA; Lorenzo I; Sly LM; Beaudet AL; Staite ND
J Immunol; 1996 Oct; 157(7):3153-8. PubMed ID: 8816427
[TBL] [Abstract][Full Text] [Related]
36. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is associated with anti-CII B-cell activation.
Holmdahl R; Vingsbo C; Malmström V; Jansson L; Holmdahl M
J Autoimmun; 1994 Dec; 7(6):739-52. PubMed ID: 7888032
[TBL] [Abstract][Full Text] [Related]
37. Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects.
Ushiyama S; Yamada T; Murakami Y; Kumakura S; Inoue S; Suzuki K; Nakao A; Kawara A; Kimura T
Eur J Pharmacol; 2008 Jan; 578(1):76-86. PubMed ID: 17920584
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats.
García-González A; Lotz M; Ochoa JL
Rev Invest Clin; 2009; 61(3):212-20. PubMed ID: 19736810
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the primary lesion of adjuvant. induced polyarthritis in rats (18-hour arthritis test) for specific detection of clinically effective anti-arthritic drugs.
Sofia RD; Knobloch LC; Vassar HB
J Pharmacol Exp Ther; 1975 Jun; 193(3):918-31. PubMed ID: 807714
[TBL] [Abstract][Full Text] [Related]
40. Specificity of anti-type II collagen antibody response in rats.
Kakimoto K; Hirofuji T; Koga T
Clin Exp Immunol; 1984 Jul; 57(1):57-62. PubMed ID: 6744675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
